Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Kite Pharma logo — At Kite, a Gilead Company, our singular focus is cell therap...

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

Founded 2009 United States Santa Monica, United States 4013 employees Acquired Total: $12.56B Biotechnology, Health Care +1

General Information

Company Name Kite Pharma
Founded Year 2009
Location United States Santa Monica, United States
Founders / Decision Makers
Team member Team member
Employees 4013
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Acquired
Business Model B2B, B2C, B2D
Revenue Model Product Sales, Service Fee, Value Based Pricing
Social

BounceWatch is an independent company data service, not affiliated with Kite Pharma. To contact Kite Pharma, visit kitepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kite Pharma compare?

A PDF of Kite Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kite Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kite Pharma

Kite Pharma, based in Santa Monica, United States, specializes in cell therapy aimed at treating and curing cancer. The company serves cancer patients, healthcare providers, research institutions, biopharmaceutical investors, and oncology care centers.

Founded in 2009, Kite Pharma offers services such as cell therapy development, manufacturing of CAR T-cell therapies, clinical trials and research, patient support and resources, and external research programs. Operating on a B2B, B2C, and B2D business model, the company generates revenue through product sales, service fees, and value-based pricing.

Business keywords: Cell Therapy, Cancer Immunotherapy, Hematologic Malignancies, Engineered T Cell Therapy, Autologous Cell Therapy, Immune-Based Targeted Therapies, Tumor Cell Reengineering, Cancer Treatment Innovation, Patient-Specific Treatments, Biopharmaceutical Manufacturing, T Cells Engineering, Oncology Therapeutics, Immune System Stimulation

Services & Products

Cell Therapy Development
Manufacturing of CAR T-cell Therapies
Clinical Trials and Research
Patient Support and Resources
External Research Programs

Target Customers

Cancer Patients Healthcare Providers Research Institutions Biopharmaceutical Investors Oncology Care Centers

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $11.90B 1
Gilead Sciences
Gilead Sciences
01 Aug 2017
Post-IPO Equity $250.10M -
01 Dec 2015
Post-IPO Equity $216.40M -
01 Dec 2014
Debt Financing $146.60M -
01 Jun 2014
Series A $35.00M 3
Alta Partners Two River Riverbank Capital Securities
Alta Partners, Two River +1
01 May 2013
Debt Financing $250.00K -
01 Dec 2012
Series A $15.00M 2
Two River Riverbank Capital Securities
Two River, Riverbank Capital Securities
01 Mar 2011
Spinout Undisclosed 3
Science
Science, University of California, Los Angeles +1
01 Jan 2009

Latest News

View All
Elicera on AstraZeneca’s acquisition of Neogene Therapeutics — Biostock.se
Elicera on AstraZeneca’s acquisition of Neogene Therapeutics
Biostock.se Feb 08, 2023
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy — Businesswire.com
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
Businesswire.com Nov 29, 2022
Neogene Picks Cell Therapy Hub Santa Monica as U.S. Headquarters — Biospace.com
Neogene Picks Cell Therapy Hub Santa Monica as U.S. Headquarters
Biospace.com Jun 21, 2021

Kite Pharma Alternatives & Competitors

Kite Pharma vs
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. United States

Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is...

IPO
925 employees
Biotechnology, Health Care
Compare Kite Pharma vs Iovance Biotherapeutics, Inc.
Kite Pharma vs
Nkarta, Inc.
Nkarta, Inc. United States

A New Way Forward for Autoimmune Disease

Post-IPO Equity
157 employees
Biotechnology, Health Care
Kite Pharma vs
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. United States

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS...

Series C
128 employees
Biotechnology, Health and Wellness
Also compare with: Kite Pharma vs Arcellx Arcellx Kite Pharma vs 2seventy bio 2seventy bio

FAQ About Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Kite Pharma was founded in 2009.
Kite Pharma is headquartered in Santa Monica, United States.
Kite Pharma operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Cell Therapy, Cancer Immunotherapy, Hematologic Malignancies and Engineered T Cell Therapy. Its customers include Cancer Patients, Healthcare Providers and Research Institutions.
Kite Pharma has a B2B, B2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Value Based Pricing.
Kite Pharma has approximately 4013 employees.
Kite Pharma has completed 8 funding rounds, raising a total of $12.56B. The latest funding stage is Acquired.
Kite Pharma offers: Cell Therapy Development, Manufacturing of CAR T-cell Therapies, Clinical Trials and Research, Patient Support and Resources, External Research Programs.
Top alternatives and competitors to Kite Pharma include Iovance Biotherapeutics, Inc., Nkarta, Inc., Aspen Neuroscience, Inc., Neogene Therapeutics, Fate Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kite Pharma and Iovance Biotherapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kite Pharma, https://bouncewatch.com/company/kite-pharma, updated 29 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes